False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
Yuebi Hu(Dana-Farber Cancer Institute), Geoffrey R. Oxnard(Foundation Medicine (United States)), Nora Feeney(Dana-Farber Cancer Institute), Kwok‐Kin Wong(NYU Langone Health), Pasi A. Jänne(Harvard University), Cloud P. Paweletz(Massachusetts General Hospital), Nicolas Guibert(Université Fédérale de Toulouse Midi-Pyrénées), Bryan C. Ulrich(Dana-Farber Cancer Institute), Patrick H. Lizotte(Harvard University), Julianna Supplee(Dana-Farber Cancer Institute), Mark M. Awad(Memorial Sloan Kettering Cancer Center), Yanan Kuang(Dana-Farber Cancer Institute)
Cited by 445
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k